May 17, 2020

BPA fillings may cause behavioral problems

Bisphenol A
BPA
Children's Behaviour
Dentistry
Admin
2 min
BPA fillings may cause behavioral problems
Children who get dental fillings made with a chemical called bisphenol A (BPA) are more likely to develop emotional and behavioural problems a few year...

Children who get dental fillings made with a chemical called bisphenol A (BPA) are more likely to develop emotional and behavioural problems a few years later, according to a new study.

Researchers recorded a small effect on behaviour in children who have received fillings containing BPA, part of a plastic composite which is favoured in dental surgery because of its more ‘natural looking’ tooth colouring. After five years, parents and kids answered a series of questions about anxiety, depression, attitudes at school and overall behaviour.

To read the latest edition of Healthcare Global, click here

 

Researchers found that kids who had multiple fillings made using BPA (and who’d had those fillings for a while)  scored two to six points worse on a 100-point behaviour measures than those who had had none of those fillings.

Behaviour problems were especially common in children who’d had the fillings for a long time, particularly in those who had fillings on chewing surfaces. This supports the idea that some fillings begin to break down over time with chewing, and leach certain chemicals.

This study could be linked to previous research which linked prenatal exposure to BPA with hyperactivity and anxiety, particularly in girls.

The overall effects of BPA are still unclear, however. Researchers are still unclear as to how much chemical content leaches from BPA plastics, which are also used in food packaging and canned goods. This study did not measure the BPA levels, and had no way of knowing if the fillings were leaching out other chemicals.

Nancy Maserejian from New England Research Institutes in Watertown, Massachusetts conducted the study. She told Reuters Health: "It's a controversial topic in dental research, how much really does leach (from fillings)… and whether or not that would have an effect. It's generally assumed that the amounts leached are tiny."

“We didn't measure BPA, and we don't know whether BPA was in (the fillings)," added Maserejian "There are other chemicals used in these composites, and BPA isn't directly used in them. We don't really know what the health effects of these other chemicals are."

She assured parents that they shouldn’t be worried, claiming that the average difference in behaviour issues between kids with different types of fillings “would not be noticeable for most children”.

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

AI
NHS
skincancer
Cancer
2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article